A CHALLENGES AND CLINICAL IMPLICATION IN DAPSONEINDUCED HYPERSENSITIVITY SYNDROME IN BORDERLINE TUBERCULOID HANSEN’S DISEASE. CDF 2024, 53 (03), 3231-3236. https://doi.org/10.48047/5490j172.